Shuttle Pharmaceuticals Holdings (SHPH) Change in Acquisitions & Divestments (2023 - 2024)

Shuttle Pharmaceuticals Holdings (SHPH) recorded quarterly Change in Acquisitions & Divestments of $1.7 million in Q3 2024, up 41.6% quarter-over-quarter from $1.2 million in Q2 2024.

Shuttle Pharmaceuticals Holdings (SHPH) Change in Acquisitions & Divestments (2023 - 2024) Analysis & Trends

Shuttle Pharmaceuticals Holdings' Change in Acquisitions & Divestments history runs 2 years deep, the most recent figure standing at $1.7 million for Q3 2024.

  • In Q3 2024, Change in Acquisitions & Divestments changed N/A year-over-year to $1.7 million; the TTM figure through Dec 2024 stood at $3.0 million (changed N/A YoY), while the FY2024 annual figure was $3.0 million, up 1475.0% from the prior year.
  • Change in Acquisitions & Divestments was $1.7 million for Q3 2024 at Shuttle Pharmaceuticals Holdings, up from $1.2 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $1.7 million in Q3 2024 to a low of $107895.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Shuttle Pharmaceuticals Holdings 2.17 Mn 1.11 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2024 1.66 Mn
Sep 30, 2024 1.66 Mn
Jun 30, 2024 1.18 Mn
Jun 30, 2024 1.18 Mn
Mar 31, 2024 120,000.00
Mar 31, 2024 120,000.00
Dec 31, 2023 107,895.00
Dec 31, 2023 107,895.00